GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Beneish M-Score

MicroPort CardioFlow Medtech (HKSE:02160) Beneish M-Score : -2.08 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.08 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for MicroPort CardioFlow Medtech's Beneish M-Score or its related term are showing as below:

HKSE:02160' s Beneish M-Score Range Over the Past 10 Years
Min: -3.26   Med: -0.12   Max: 7.15
Current: -2.08

During the past 6 years, the highest Beneish M-Score of MicroPort CardioFlow Medtech was 7.15. The lowest was -3.26. And the median was -0.12.


MicroPort CardioFlow Medtech Beneish M-Score Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Beneish M-Score Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - 7.15 1.84 -3.26 -2.08

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.84 - -3.26 - -2.08

Competitive Comparison of MicroPort CardioFlow Medtech's Beneish M-Score

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Beneish M-Score falls into.



MicroPort CardioFlow Medtech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of MicroPort CardioFlow Medtech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.8213+0.528 * 0.9444+0.404 * 0.8089+0.892 * 1.3119+0.115 * 0.8986
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9405+4.679 * -0.102653-0.327 * 1.1349
=-2.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$147.5 Mil.
Revenue was HK$367.7 Mil.
Gross Profit was HK$251.5 Mil.
Total Current Assets was HK$2,232.8 Mil.
Total Assets was HK$2,818.8 Mil.
Property, Plant and Equipment(Net PPE) was HK$215.4 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$80.5 Mil.
Selling, General, & Admin. Expense(SGA) was HK$320.7 Mil.
Total Current Liabilities was HK$211.7 Mil.
Long-Term Debt & Capital Lease Obligation was HK$45.8 Mil.
Net Income was HK$-515.8 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$-226.4 Mil.
Total Receivables was HK$61.7 Mil.
Revenue was HK$280.3 Mil.
Gross Profit was HK$181.1 Mil.
Total Current Assets was HK$2,536.9 Mil.
Total Assets was HK$3,351.6 Mil.
Property, Plant and Equipment(Net PPE) was HK$269.9 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$87.3 Mil.
Selling, General, & Admin. Expense(SGA) was HK$259.9 Mil.
Total Current Liabilities was HK$197.9 Mil.
Long-Term Debt & Capital Lease Obligation was HK$71.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(147.455 / 367.745) / (61.716 / 280.324)
=0.400971 / 0.22016
=1.8213

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(181.053 / 280.324) / (251.494 / 367.745)
=0.64587 / 0.683881
=0.9444

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2232.77 + 215.445) / 2818.786) / (1 - (2536.917 + 269.927) / 3351.552)
=0.131465 / 0.162524
=0.8089

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=367.745 / 280.324
=1.3119

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(87.344 / (87.344 + 269.927)) / (80.522 / (80.522 + 215.445))
=0.244475 / 0.272064
=0.8986

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(320.723 / 367.745) / (259.934 / 280.324)
=0.872134 / 0.927263
=0.9405

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((45.842 + 211.737) / 2818.786) / ((71.947 + 197.914) / 3351.552)
=0.091379 / 0.080518
=1.1349

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-515.754 - 0 - -226.396) / 2818.786
=-0.102653

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

MicroPort CardioFlow Medtech has a M-score of -2.08 suggests that the company is unlikely to be a manipulator.


MicroPort CardioFlow Medtech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.
Executives
China Renaissance Holdings Limited 2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Microport Scientific Corporation 2201 Interest of corporation controlled by you
Shanghai Microport Limited 2101 Beneficial owner
China International Capital Corporation Limited 2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd. 2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership) 2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd. 2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines